» Articles » PMID: 32072994

MiRNA-411 Regulates Chondrocyte Autophagy in Osteoarthritis by Targeting Hypoxia-Inducible Factor 1 Alpha (HIF-1α)

Overview
Journal Med Sci Monit
Date 2020 Feb 20
PMID 32072994
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

BACKGROUND Osteoarthritis (OA) is the most common joint disease and is characterized by the progressive degeneration of articular cartilage. The molecular basis of OA involves various factors and has not been fully clarified. Autophagy is a conserved catabolic process that involves cellular degradation through the lysosomal machinery. MATERIAL AND METHODS We found that miRNA-411 regulates chondrocyte autophagy in OA by targeting hypoxia-inducible factor 1 alpha (HIF-1alpha) and identified the related molecular mechanism. OA condition in chondrocyte C28/I2 cells was induced by treatment with interleukin 1 beta (IL-1ß). The protein expressions of LC3, p62, HIF-1alpha, ULK-1, and Beclin-1 were assessed by Western blot analysis, and LC3 expression was assessed by immunofluorescence. RESULTS TargetScan analysis showed that HIF-1alpha mRNA is directly targeted by miR-411, which was confirmed by luciferase reporter assay. miR-411 mimic decreased HIF-1alpha levels in chondrocytes while miR-411 inhibitor increased HIF-1alpha levels in chondrocytes. Furthermore, expression of LC3, ULK-1, P62, and Beclin-1 in chondrocytes was induced by miR-411 inhibitor and was downregulated by miR-411 mimics. In addition, miR-411 mimics reduced the expression level of LC3, as determined by immunofluorescence analysis. CONCLUSIONS Our results demonstrate that miR-411 promotes chondrocyte autophagy by targeting HIF-1alpha, suggesting that regulating HIF-1alpha by miR-411 might be a therapeutic strategy for OA.

Citing Articles

Cartilage Homeostasis under Physioxia.

Arai Y, Cha R, Nakagawa S, Inoue A, Nakamura K, Takahashi K Int J Mol Sci. 2024; 25(17).

PMID: 39273346 PMC: 11395513. DOI: 10.3390/ijms25179398.


Autophagy in Osteoarthritis: A Double-Edged Sword in Cartilage Aging and Mechanical Stress Response: A Systematic Review.

Lee D, Bahar M, Kim C, Seo M, Song M, Song S J Clin Med. 2024; 13(10).

PMID: 38792546 PMC: 11122125. DOI: 10.3390/jcm13103005.


Glucosamine and Silibinin Alter Cartilage Homeostasis through Glycosylation and Cellular Stresses in Human Chondrocyte Cells.

Hsu Y, Huang T, Liu S, Huang S, Chen Y, Wu C Int J Mol Sci. 2024; 25(9).

PMID: 38732122 PMC: 11084729. DOI: 10.3390/ijms25094905.


Mesenchymal Stem Cells Cultured in a 3D Microgel Environment Containing Platelet-Rich Plasma Significantly Modify Their Chondrogenesis-Related miRNA Expression.

Mata M, Salvador-Clavell R, Rodenas-Rochina J, Sancho-Tello M, Gallego Ferrer G, Ribelles J Int J Mol Sci. 2024; 25(2).

PMID: 38256011 PMC: 10815493. DOI: 10.3390/ijms25020937.


Regulatory mechanisms of autophagy-related ncRNAs in bone metabolic diseases.

Yan B, Li Z, Su H, Xue H, Qiu D, Xu Z Front Pharmacol. 2023; 14:1178310.

PMID: 38146458 PMC: 10749346. DOI: 10.3389/fphar.2023.1178310.


References
1.
Hill S, Wrobel L, Rubinsztein D . Post-translational modifications of Beclin 1 provide multiple strategies for autophagy regulation. Cell Death Differ. 2018; 26(4):617-629. PMC: 6460389. DOI: 10.1038/s41418-018-0254-9. View

2.
Musumeci G, Castrogiovanni P, Trovato F, Weinberg A, Al-Wasiyah M, Alqahtani M . Biomarkers of Chondrocyte Apoptosis and Autophagy in Osteoarthritis. Int J Mol Sci. 2015; 16(9):20560-75. PMC: 4613218. DOI: 10.3390/ijms160920560. View

3.
DAdamo S, Cetrullo S, Minguzzi M, Silvestri Y, Borzi R, Flamigni F . MicroRNAs and Autophagy: Fine Players in the Control of Chondrocyte Homeostatic Activities in Osteoarthritis. Oxid Med Cell Longev. 2017; 2017:3720128. PMC: 5497632. DOI: 10.1155/2017/3720128. View

4.
Wang G, Zhang Y, Zhao X, Meng C, Ma L, Kong Y . MicroRNA-411 inhibited matrix metalloproteinase 13 expression in human chondrocytes. Am J Transl Res. 2015; 7(10):2000-6. PMC: 4656776. View

5.
Long M, Li X, Li L, Dodson M, Zhang D, Zheng H . Multifunctional p62 Effects Underlie Diverse Metabolic Diseases. Trends Endocrinol Metab. 2017; 28(11):818-830. DOI: 10.1016/j.tem.2017.09.001. View